|
TOC
|
|
1. Introduction
|
|
1.1. Report Description
|
|
1.2. Overview of the Pharmaceutical Customer Relationship Management Software Market: Definition
|
|
1.3. Market Research Scope
|
|
1.4. Market Covered: Regional Scope
|
|
1.5. Years Considered for The Study
|
|
2. Research Methodology
|
|
2.1. Description
|
|
2.1.1. Market Research Process
|
|
2.1.2. Information Procurement
|
|
2.1.3. Data Analysis
|
|
2.1.4. Market Formulation & Validation
|
|
3. Executive Summary
|
|
3.1. Key Insight of the Study
|
|
3.2. Segmentation Outlook By Component
|
|
3.3. Segmentation Outlook By Deployment
|
|
3.4. Segmentation Outlook By Function
|
|
3.5. Segmentation Outlook By End User
|
|
3.6. Segmentation Outlook By Application
|
|
3.7 Segmentation Outlook by Region
|
|
4. Pharmaceutical Customer Relationship Management Software Market – Industry Outlook
|
|
4.1. Impact of COVID-19 on the Market
|
|
4.2. Market Attractiveness Analysis
|
|
4.2.1. Market Attractiveness Analysis By Component
|
|
4.2.2. Market Attractiveness Analysis by Region
|
|
4.3. Industry Swot Analysis
|
|
4.3.1. Strength
|
|
4.3.2. Weakness
|
|
4.3.3. Opportunities
|
|
4.3.4. Threats
|
|
4.4. Porter's Five Forces Analysis
|
|
4.4.1. Threat of New Entrants
|
|
4.4.2. Bargaining Power of Suppliers
|
|
4.4.3. Bargaining Power of Buyers
|
|
4.4.4. Threat of Substitutes
|
|
4.4.5. Industry Rivalry
|
|
4.5. Pointers Covered at the Micro Level
|
|
4.5.1. Customers
|
|
4.5.2. The Supply and Demand Side
|
|
4.5.3. Shareholders and Investors
|
|
4.5.4. Media, Advertising, and Marketing
|
|
4.6. Pointers Covered at the Macro Level
|
|
4.6.1. Economic Factors
|
|
4.6.2. Technological Advancements
|
|
4.6.3. Regulatory Environment
|
|
4.6.4. Societal and Cultural Trends
|
|
4.7. Value Chain
|
|
4.7.1. Raw Material Sourcing
|
|
4.7.2. Manufacturing/Processing
|
|
4.7.3. Quality Control and Testing
|
|
4.7.4. Packaging and Distribution
|
|
4.7.5. End-Use Segment 4S
|
|
4.8. Impact of AI Across Leading Economies
|
|
5. Market Overview and Key Dynamics
|
|
5.1. Market Dynamics
|
|
5.2. Drivers
|
|
5.2.1. Driver 1
|
|
5.2.2. Driver 2
|
|
5.3. Restraints and Challenges
|
|
5.3.1. Restraints and Challenges 1
|
|
5.3.2. Restraints and Challenges 2
|
|
5.4. Opportunities
|
|
5.4.1. Opportunity 1
|
|
5.4.2. Opportunity 2
|
|
6. Pharmaceutical Customer Relationship Management Software Market Insights and Forecast Analysis
|
|
6.1. Pharmaceutical Customer Relationship Management Software Market Analysis and Forecast
|
|
7. Pharmaceutical Customer Relationship Management Software Market Insights & Forecast Analysis, By Component – 2021 to 2033
|
|
7.1. Pharmaceutical Customer Relationship Management Software Market Analysis and Forecast, By Component
|
|
7.1.1. Software
|
|
7.1.2. Services
|
|
7.1.3. Consulting
|
|
7.1.4. Implementation
|
|
7.1.5. Integration
|
| |
|
8. Pharmaceutical Customer Relationship Management Software Market Insights & Forecast Analysis, By Deployment – 2021 to 2033
|
|
8.1. Pharmaceutical Customer Relationship Management Software Market Analysis and Forecast, By Deployment
|
|
8.1.1. Cloud-Based
|
|
8.1.2. On-Premise
|
|
8.1.3. Hybrid
|
|
8.1.4. SaaS
|
|
8.1.5. Private Cloud
|
| |
|
9. Pharmaceutical Customer Relationship Management Software Market Insights & Forecast Analysis, By Function – 2021 to 2033
|
|
9.1 Pharmaceutical Customer Relationship Management Software Market Analysis and Forecast, By Function
|
|
9.1.1. Sales Force Automation
|
|
9.1.2. Marketing Automation
|
|
9.1.3. Customer Service
|
|
9.1.4. Analytics
|
|
9.1.5. Contact Management
|
| |
|
10. Pharmaceutical Customer Relationship Management Software Market Insights & Forecast Analysis, By End User – 2021 to 2033
|
|
10.1 Pharmaceutical Customer Relationship Management Software Market Analysis and Forecast, By End User
|
|
10.1.1. Pharmaceutical Companies
|
|
10.1.2. Biotechnology Companies
|
|
10.1.3. CROs
|
|
10.1.4. Medical Device Companies
|
|
10.1.5. Distributors
|
| |
|
11. Pharmaceutical Customer Relationship Management Software Market Insights & Forecast Analysis, By Application – 2021 to 2033
|
|
11.1 Pharmaceutical Customer Relationship Management Software Market Analysis and Forecast, By Application
|
|
11.1.1. HCP Engagement
|
|
11.1.2. Patient Engagement
|
|
11.1.3. Sales Management
|
|
11.1.4. Field Force Management
|
|
11.1.5. Omnichannel Marketing
|
| |
|
12 Pharmaceutical Customer Relationship Management Software Market Insights & Forecast Analysis, By Region – 2021 to 2033
|
|
12.1 Pharmaceutical Customer Relationship Management Software Market, By Region
|
|
12.2 North America Pharmaceutical Customer Relationship Management Software Market, By Component
|
|
12.2.1 North America Pharmaceutical Customer Relationship Management Software Market, By Component, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.3 North America Pharmaceutical Customer Relationship Management Software Market, By Deployment
|
|
12.3.1 North America Pharmaceutical Customer Relationship Management Software Market, By Deployment, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.4 North America Pharmaceutical Customer Relationship Management Software Market, By Function
|
|
12.4.1 North America Pharmaceutical Customer Relationship Management Software Market, By Function, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.5 North America Pharmaceutical Customer Relationship Management Software Market, By End User
|
|
12.5.1 North America Pharmaceutical Customer Relationship Management Software Market, By End User, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.6 North America Pharmaceutical Customer Relationship Management Software Market, By Application
|
|
12.6.1 North America Pharmaceutical Customer Relationship Management Software Market, By Application, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.7 North America Pharmaceutical Customer Relationship Management Software Market Insights & Forecast Analysis, BY Segmentation and Country – 2021 - 2033
|
|
12.8 North America Pharmaceutical Customer Relationship Management Software Market, By Country
|
|
12.8.1 United States
|
|
12.8.2 Canada
|
|
12.8.3 Mexico
|
|
12.9 Europe Pharmaceutical Customer Relationship Management Software Market, By Component
|
|
12.9.1 Europe Pharmaceutical Customer Relationship Management Software Market, By Component, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.10 Europe Pharmaceutical Customer Relationship Management Software Market, By Deployment
|
|
12.10.1 Europe Pharmaceutical Customer Relationship Management Software Market, By Deployment, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.11 Europe Pharmaceutical Customer Relationship Management Software Market, By Function
|
|
12.11.1 Europe Pharmaceutical Customer Relationship Management Software Market, By Function, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.12 Europe Pharmaceutical Customer Relationship Management Software Market, By End User
|
|
12.12.1 Europe Pharmaceutical Customer Relationship Management Software Market, By End User, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.13 Europe Pharmaceutical Customer Relationship Management Software Market, By Application
|
|
12.13.1 Europe Pharmaceutical Customer Relationship Management Software Market, By Application, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.14 Europe Pharmaceutical Customer Relationship Management Software Market Insights & Forecast Analysis, BY Segmentation and Country – 2021 - 2033
|
|
12.15 Europe Pharmaceutical Customer Relationship Management Software Market, By Country
|
|
12.15.1 Germany
|
|
12.15.2 United Kingdom
|
|
12.15.3 France
|
|
12.15.4 Italy
|
|
12.15.5 Spain
|
|
12.15.6 Rest of Europe
|
|
12.16 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By Component
|
|
12.16.1 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By Component, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.17 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By Deployment
|
|
12.17.1 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By Deployment, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.18 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By Function
|
|
12.18.1 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By Function, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.19 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By End User
|
|
12.19.1 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By End User, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.20 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By Application
|
|
12.20.1 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By Application, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.21 Asia Pacific Pharmaceutical Customer Relationship Management Software Market Insights & Forecast Analysis, BY Segmentation and Country – 2021 - 2033
|
|
12.22 Asia Pacific Pharmaceutical Customer Relationship Management Software Market, By Country
|
|
12.22.1 China
|
|
12.22.2 India
|
|
12.22.3 Japan
|
|
12.22.4 Australia
|
|
12.22.5 South Korea
|
|
12.22.6 Rest of Asia
|
|
12.23 South America Pharmaceutical Customer Relationship Management Software Market, By Component
|
|
12.23.1 South America Pharmaceutical Customer Relationship Management Software Market, By Component, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.24 South America Pharmaceutical Customer Relationship Management Software Market, By Deployment
|
|
12.24.1 South America Pharmaceutical Customer Relationship Management Software Market, By Deployment, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.25 South America Pharmaceutical Customer Relationship Management Software Market, By Function
|
|
12.25.1 South America Pharmaceutical Customer Relationship Management Software Market, By Function, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.26 South America Pharmaceutical Customer Relationship Management Software Market, By End User
|
|
12.26.1 South America Pharmaceutical Customer Relationship Management Software Market, By End User, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.27 South America Pharmaceutical Customer Relationship Management Software Market, By Application
|
|
12.27.1 South America Pharmaceutical Customer Relationship Management Software Market, By Application, Revenue (USD Billion), (2721 -2733), CAGR (%) (2726-2733)
|
|
12.28 South America Pharmaceutical Customer Relationship Management Software Market Insights & Forecast Analysis, BY Segmentation and Country – 2021 - 2033
|
|
12.29 South America Pharmaceutical Customer Relationship Management Software Market, By Country
|
|
12.29.1 Brazil
|
|
12.29.2 Argentina
|
|
12.29.3 Rest of South America
|
|
12.30 Middle East and Africa Pharmaceutical Customer Relationship Management Software Market, By Component
|
|
12.30.1 Middle East and Africa Pharmaceutical Customer Relationship Management Software Market, By Deployment, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.31 Middle East and Africa Pharmaceutical Customer Relationship Management Software Market, By Deployment
|
|
12.31.1 Middle East and Africa Pharmaceutical Customer Relationship Management Software Market, By Deployment, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.32 Middle East and Africa Pharmaceutical Customer Relationship Management Software Market, By Function
|
|
12.32.1 Middle East and Africa Pharmaceutical Customer Relationship Management Software Market, By Function, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.33Middle East and Africa Pharmaceutical Customer Relationship Management Software Market, By End User
|
|
12.33.1 Middle East and Africa Pharmaceutical Customer Relationship Management Software Market, By End User, Revenue (USD Billion), (2021 -2033), CAGR (%) (2026-2033)
|
|
12.34 Middle East and Africa Pharmaceutical Customer Relationship Management Software Market, By Application
|
|
12.34.1 Middle East and Africa Pharmaceutical Customer Relationship Management Software Market, By Application, Revenue (USD Billion), (2721 -2733), CAGR (%) (2726-2733)
|
|
12.35 Middle East and Africa Pharmaceutical Customer Relationship Management Software Market Insights & Forecast Analysis, BY Segmentation and Country – 2021 - 2033
|
|
12.36 Middle East and Africa Pharmaceutical Customer Relationship Management Software Market, By Country
|
|
12.36.1 Saudi Arabia
|
|
12.36.2United Arab Emirates
|
|
12.36.3 South Africa
|
|
12.36.4 Rest of Middle East and Africa
|
|
13 Pharmaceutical Customer Relationship Management Software Market: Competitive Landscape
|
|
13.1 Competitive Rivalry and Division
|
|
13.2 Company Market Share Analysis
|
|
13.3 Pharmaceutical Customer Relationship Management Software Market: Top Winning Strategies
|
|
13.4 Pharmaceutical Customer Relationship Management Software Market: Competitive Heatmap Analysis
|
|
14 Pharmaceutical Customer Relationship Management Software Market: Company Profiles
|
|
14.1 Veeva Systems
|
|
14.1.1 Overview of Business
|
|
14.1.2 Economic Performance of the Company
|
|
14.1.3 Key Executives
|
|
14.1.4 Portfolio of Products
|
|
14.1.5 Company Strategy Mapping
|
|
14.2 Salesforce
|
|
14.3 Microsoft
|
|
14.4 IQVIA
|
|
14.5 Oracle
|
|
14.6 SAP
|
|
14.7 ZS Associates
|
|
14.8 Pitcher AG
|
|
14.9 Aktana
|
|
14.10 Salesforce Life Sciences
|
|
14.11 Cegedim
|
|
14.12 Indegene
|
|
14.13 Pegasystems
|
|
14.14 Creatio
|
|
14.15 ServiceNow
|